Todd C. Brady
2023
In 2023, Todd C. Brady earned a total compensation of $3.7M as President and Chief Executive Officer at Aldeyra Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,733 |
|---|---|
| Option Awards | $1,236,598 |
| Salary | $581,170 |
| Stock Awards | $1,613,950 |
| Other | $13,200 |
| Total | $3,684,651 |
Brady received $1.6M in stock awards, accounting for 44% of the total pay in 2023.
Brady also received $239.7K in non-equity incentive plan, $1.2M in option awards, $581.2K in salary and $13.2K in other compensation.
Rankings
In 2023, Todd C. Brady's compensation ranked 214th out of 2,978 executives tracked by ExecPay. In other words, Brady earned more than 92.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 214 out of 2,978 | 93rd |
Division Manufacturing | 114 out of 1,637 | 93rd |
Major group Chemicals And Allied Products | 75 out of 906 | 92nd |
Industry group Drugs | 73 out of 869 | 92nd |
Industry Pharmaceutical Preparations | 45 out of 627 | 93rd |
Source: SEC filing on April 22, 2024.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2023.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019